- Home
- CEPU vs JANX Comparison
CEPU vs JANX Comparison
Compare CEPU & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- JANX
- Stock Information
- Founded
- CEPU 1989
- JANX 2017
- Country
- CEPU Argentina
- JANX United States
- Employees
- CEPU N/A
- JANX N/A
- Industry
- CEPU Electric Utilities: Central
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- CEPU Utilities
- JANX Health Care
- Exchange
- CEPU Nasdaq
- JANX Nasdaq
- Market Cap
- CEPU 1.4B
- JANX 1.4B
- IPO Year
- CEPU 2018
- JANX 2021
- Fundamental
- Price
- CEPU $15.87
- JANX $27.02
- Analyst Decision
- CEPU Strong Buy
- JANX Strong Buy
- Analyst Count
- CEPU 1
- JANX 11
- Target Price
- CEPU $17.50
- JANX $76.55
- AVG Volume (30 Days)
- CEPU 656.2K
- JANX 1.2M
- Earning Date
- CEPU 11-12-2025
- JANX 11-06-2025
- Dividend Yield
- CEPU 1.95%
- JANX N/A
- EPS Growth
- CEPU N/A
- JANX N/A
- EPS
- CEPU 0.12
- JANX N/A
- Revenue
- CEPU $628,806,380.00
- JANX $439,000.00
- Revenue This Year
- CEPU $11.09
- JANX N/A
- Revenue Next Year
- CEPU $10.25
- JANX $89.91
- P/E Ratio
- CEPU $16.87
- JANX N/A
- Revenue Growth
- CEPU N/A
- JANX N/A
- 52 Week Low
- CEPU $7.43
- JANX $21.73
- 52 Week High
- CEPU $16.60
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- CEPU 77.45
- JANX 52.81
- Support Level
- CEPU $13.66
- JANX $27.40
- Resistance Level
- CEPU $16.54
- JANX $29.21
- Average True Range (ATR)
- CEPU 0.91
- JANX 1.83
- MACD
- CEPU 0.72
- JANX 0.01
- Stochastic Oscillator
- CEPU 91.59
- JANX 37.35
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.